查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球經顱多普勒超聲市場 - 2023-2030
市場調查報告書
商品編碼
1345373

全球經顱多普勒超聲市場 - 2023-2030

Global Transcranial Doppler Ultrasound Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

2022年，全球經顱多普勒超聲市場達到2730萬美元，預計到2030年將達到4300萬美元，2023-2030年預測期間年複合成長率為6.7%。經顱多普勒超聲檢查可檢測由血栓、血管狹窄部分、蛛網膜下腔出血引起的血管痙攣和微小血栓引起的中風。這是一種無痛測試，利用聲波來檢測影響大腦血流的醫療問題。

此外，疾病患病率的增加可以擴大經顱多普勒超聲市場規模。由於美國和加拿大等國家醫療保健擴張的增加，北美地區的市場需求不斷增加。 Viasonix、Rimed、Dawei Medical 等重要參與者正在該市場積極營運。

市場動態

鐮狀細胞病數量的增加可以促進市場成長

鐮狀細胞病數量的增加可以促進市場成長。例如，鐮狀細胞病 (SCD) 影響著大約 100,000 名美國人。每 365 名黑人或非裔美國人新生兒中就有 1 名患有 SCD。每 16,300 名西班牙裔美國人新生兒中就有 1 人患有 SCD。大約三分之一的黑人或非裔美國嬰兒出生時就患有鐮狀細胞性狀 (SCT)。

此外，經顱多普勒超聲檢查是患有某些類型鐮狀細胞病的兒童的一項重要檢查。中風是鐮狀細胞病 (SCD) 兒童最嚴重的併發症之一，影響約 5-10% 的兒童，發病率在生命的第一個十年達到高峰。該測試可以幫助確定孩子中風的風險。因此，鐮狀細胞病數量的增加可以促進市場成長。

缺血性中風發病率的上升可以加速市場成長

缺血性中風患病率的增加可以促進市場成長。例如，美國每年有超過 79 萬人中風。其中約 610,000 例為首次或新中風。大約有 185,000 例中風（近四分之一）發生在患有中風史的人身上。大約 87% 的中風是缺血性中風，即流向大腦的血液受阻。

它可以檢測由血栓、血管狹窄部分、蛛網膜下腔出血引起的血管痙攣、微小血栓等引起的中風。經顱多普勒（TCD）是診斷急性缺血性中風最有用的工具之一。它提供了有關微栓子、腦血管狹窄程度和側支血流的有價值的資訊。因此，缺血性中風患病率的增加可以促進市場成長。

與 TCD 相關的限制可能會阻礙市場成長

TCD 的局限性是在顱頂內對正確的動脈進行聲波傳導的技術挑戰。獲得老年患者的多普勒波形也可能很困難，因為超聲能量穿過此類患者（12-19% 的急性中風患者）典型的厚顱骨時會衰減。由於在較慢的幀速率下對資訊進行了更多的平均，緩慢移動的軟組織訊號顯示為閃光偽影。因此，與 TCD 相關的限制可能會阻礙市場成長。

目錄

第 1 章：方法和範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義和概述

第 3 章：執行摘要

  • 按類型分類
  • 技術片段
  • 按應用程式片段
  • 最終用戶的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 動力
      • 鐮狀細胞病數量增加
      • 缺血性中風患病率上升
    • 限制
      • 與 TCD 相關的限制
    • 機會
      • 診斷設備的進步
    • 影響分析

第 5 章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情況
    • COVID-19 期間的情況
    • COVID-19 後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商戰略舉措
  • 結論

第 7 章：按類型

  • 非雙工 TCD
  • 雙工 TCD

第 8 章：按技術

  • 連續波多普勒
  • 脈衝波多普勒

第 9 章：按應用

  • 鐮形血球貧血症
  • 急性缺血性中風
  • 顱內狹窄閉塞性疾病
  • 血管痙攣
  • 其他

第 10 章：按最終用戶

  • 醫院
  • 診斷實驗室
  • 其他

第 11 章：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Viasonix
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Rimed
  • Dawei Medical
  • Konica Minolta Healthcare India Pvt. Ltd.
  • NovoSignal Corp
  • Viasonix
  • Compumedics Germany GmbH
  • RIMED
  • Elekta AB,
  • Shenzhen Delica Medical Equipment Co., Ltd.

第 14 章：附錄

簡介目錄
Product Code: MI6737

Market Overview

The Global Transcranial Doppler Ultrasound Market reachedUS$ 27.3 million in 2022 and is expected to reach US$ 43.0 million by 2030, growing with a CAGR of 6.7% during the forecast period 2023-2030. Transcranial doppler ultrasound test detects stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, and tiny blood clots. It is a painless test that uses sound waves to detect medical problems that affect blood flow in the brain.

Furthermore, the increase in the prevalence of the diseases can elevate the transcranial doppler ultrasound market size. Due to the increase in healthcare expanditure in the countries like the U.S. and Canada, the market is experiencing an increase in demand in North American region. Significant key players like Viasonix, Rimed, Dawei Medical, and others are actively operating in the market.

Market Dynamics

Increase in the Number of Sickle Cell Diseases can Elevate the Market Growth

An increase in the number of sickle cell disorders can elevate the market growth. For instance, sickle cell diseases (SCD) affects approximately 100,000 Americans. SCD occurs among about 1 out of every 365 black or African-American births. SCD occurs among about 1 out of every 16,300 hispanic-American births. About 1 in 13 black or African-American babies is born with sickle cell trait (SCT).

Additionally, transcranial doppler ultrasound is an essential test for children with certain type of sickle cell disease. Stroke is one of the most severe complications in children suffering from sickle cell disease (SCD), affecting approximately 5-10% of children with an incidence peak in the first decade of life. This test can help determine the child's risk for stroke. Thus, an increase in the number of sickle cell diseases can elevate market growth.

Rise in the Prevalence of Ischemic Strokes can Accelerate Market Growth

The increase in the prevalence of ischemic strokes can elevate market growth. For instance, every year, more than 790,000 people in the United States have a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes-nearly 1 in 4-are in people with a previous stroke. About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked.

It can detect stroke caused by blood clots, narrowed sections of blood vessels, vasospasm due to a subarachnoid hemorrhage, tiny blood clots, and more. Transcranial doppler (TCD) is one of the most useful tools in diagnosing acute ischemic stroke. It provides valuable information about microemboli, the degree of cerebral vessel stenosis, and collateral flow. Thus, an increase in the prevalence of ischemic strokes can raise market growth.

Limitations associated with the TCDs can HamperMarket Growth

The limitations associated with the TCDs are technical challenges to insonate the correct artery within the cranial vault. It may also be difficult to obtain doppler waveforms in elderly patients because of the attenuation of ultrasound energy through a thick skull typical in such patients (12-19% of patients with acute stroke). Because of more averaging of information at slower frame rates, slow-moving soft tissue signals appear as flash artifacts. Thus, the limitations associated with TCDs can hamper market growth.

Segment Analysis

The global transcranial doppler ultrasound market is segmented based on type, technology, application, end-user and region.

The Pulsed Wave Doppler Segment Accounted for Approximately 39.8% of the Transcranial Doppler Ultrasound Market Share.

The increase in the advancements of the products can expand the growth of the segment. For instance, on February 9, 2022, Royal Philips announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on the company's Lumify handheld point-of-care ultrasound device. The pulsed wave doppler (PW Doppler) sends short pulses of ultrasound and analyzes reflected sound waves between the pulses.

By sending short and quick pulses of sound, it accurately measures the velocity of blood in a precise location and in real time. The crystals alternate rapidly between sending and analyzing ultrasound. Thus, an increase in the advancements in the products is driving the growth of the segment.

Geographical Penetration

North America Accounted for Approximately 47.2% of the Market Share in 2022.

North America is expected to hold a significant position in the transcranial doppler ultrasound market share. Due to the increase in technological advancements, innovations, and launches, there is a growth of the market in this region. For instance, on March 4, 2021, EchoNous, the leading developer of AI-driven, hand-carried ultrasound, announced the addition of both continuous wave (CW) and pulsed wave (PW) doppler capabilities to the Kosmos hardware platform, the company's flagship offering.

This innovation represents an industry first for an ultra-mobile ultrasound product, creating the first "hybrid" point-of-care ultrasound (POCUS) device, offering extensive machine-benchmarked ultrasound imaging and doppler functionality in a hand-carried unit (HCU). Thus, an increase in technological advancements in the products and the launches is driving the growth of the market.

Competitive Landscape

The major global players in the transcranial doppler ultrasound market include Viasonix, Rimed, Dawei Medical, Konica Minolta Healthcare India Pvt. Ltd., NovoSignal Corp, Viasonix, Compumedics Germany GmbH, RIMED, Elekta AB, Shenzhen Delica Medical Equipment Co., Ltd. and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant influence on the transcranial doppler ultrasound market, posing unprecedented challenges to many countries. The delayed launches and innovations have shown a negative impact on the usage of transcranial doppler ultrasound. The reduced number of product approvals has reduced market growth. Thus, COVID-19 has declined the growth of the transcranial doppler ultrasound market.

By Type

  • Non-Duplex TCDs
  • Duplex TCDs

By Technology

  • Continuous wave Doppler
  • Pulsed Wave Doppler

By Application

  • Sickle Cell Disease
  • Acute Ischemic Stroke
  • Intracranial Steno Occlusive Disease
  • Vasospasm
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Others

By Region

  • North America

U.S.

Canada

Mexico

  • Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

  • South America

Brazil

Argentina

Rest of South America

  • Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

  • Middle East and Africa

Key Developments

  • On February 28, 2023, NovaSignal announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA, in order to advance stroke research and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications in the region.
  • On July 13, 2022, Delica is pleased to announce that they have begun serving the US market with the approval of the Transcranial Doppler EMS-9M by the US FDA. Most recent wireless TCD in the world is called EMS-9M. It is a battery-powered, battery-powered system. Both in sedentary and active modes, it can be used for cerebral evaluations as well as investigations of peripheral and microvascular regions.
  • On March 15, 2022, a medical technology and data company specializing in the assessment and management of brain health announced that its NovaGuide Intelligent Ultrasound has been granted a Medical Device Licence by Health Canada. NovaGuide is now available to Canadian healthcare practitioners for use in capturing and monitoring blood flow in the brain in real-time.

Why Purchase the Report?

  • To visualize the global transcranial doppler ultrasound market segmentation based on type, technology, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of transcranial doppler ultrasound market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available in Excel consisting of key products of all the major players.

The global transcranial doppler ultrasound market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the Number of Sickle Cell Diseases
      • 4.1.1.2. Rise in the Prevalence of Ischemic Strokes
    • 4.1.2. Restraints
      • 4.1.2.1. Limitations Associated with the TCDs
    • 4.1.3. Opportunity
      • 4.1.3.1. Advancements in the Diagnostic Devices
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Non-Duplex TCDs
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Duplex TCDs

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Continuous wave Doppler
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Pulsed Wave Doppler

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Sickle Cell Disease
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Acute Ischemic Stroke
  • 9.4. Intracranial Steno Occlusive Disease
  • 9.5. Vasospasm
  • 9.6. Others

10. By End-user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.1.2. Market Attractiveness Index, By End-user
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Laboratories
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Viasonix
    • 13.1.1. Company Overview
    • 13.1.2. ProductPortfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Rimed
  • 13.3. Dawei Medical
  • 13.4. Konica Minolta Healthcare India Pvt. Ltd.
  • 13.5. NovoSignal Corp
  • 13.6. Viasonix
  • 13.7. Compumedics Germany GmbH
  • 13.8. RIMED
  • 13.9. Elekta AB,
  • 13.10. Shenzhen Delica Medical Equipment Co., Ltd.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us